Posterior Segment Eye Disorders Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Posterior Segment Eye Disease Market is Segmented by Product (Drugs and Devices (Therapeutic Devices and Diagnostic Devices), Application (Macular Degeneration, Glaucoma, Diabetic Retinopathy, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (USD million) for the above segments.

Posterior Segment Eye Disorders Market Size

Posterior Segment Eye Disorders Market Summary

Posterior Segment Eye Disorders Market Analysis

The Posterior Segment Eye Disorders Market size is estimated at USD 33.86 billion in 2025, and is expected to reach USD 44.09 billion by 2030, at a CAGR of 5.42% during the forecast period (2025-2030).

The COVID-19 pandemic disrupted the research and development activities of other therapies and drugs for medical conditions other than COVID-19. It impacted the treatment procedures and supply chains of pharmaceuticals and medical devices worldwide and the market for posterior segment eye disorders. For instance, according to a health article published in March 2021 by Oftalmologàa Barraquer, COVID-19 caused severe and irreversible consequences for people with glaucoma who suffered a very rapid evolution of the disease and have not been able to carry out follow-ups by the specialist, which, in some cases, resulted in a loss of the visual field. Therefore, the overall impact of COVID-19 on the posterior segment eye disorders market was adverse, primarily due to the decline in the diagnostics and treatment procedures of the diseases associated with the posterior segment of the eye. However, the rise in eye disorder surgeries worldwide to clear the backlogs of surgical procedures caused by the pandemic-related restrictions compensated for the market's growth in the later phase of the pandemic.

Posterior segment eye disorders are one of the major causes of visual impairments worldwide. Their prevalence is increasing gradually due to the increase in the prevalence of eye diseases, diabetes, and geriatric populations that are more vulnerable to eye ailments. With the increase in the burden of these diseases, the demand for diagnostics and treatment is increasing worldwide, driving the growth of the studied market.

According to the World Glaucoma Association (WGA) 2022 update, around 79.6 million people were living with glaucoma in 2020, and the number is projected to reach 111.8 million people by 2040. It also highlighted that at least 50% of glaucoma sufferers are unaware of their condition, and around 90% of glaucoma cases in some developing countries are undetected. Thus, the surge in glaucoma is ultimately projected to boost the posterior segment eye disorders market over the forecast period.

With the launch of new products, research and development, collaboration, mergers, and acquisitions, the market for posterior segment eye disorders is expected to grow during the forecast period. For instance, in June 2022, Iridex Corporation received regulatory approval to market and sell its Cyclo G6 platform for the treatment of glaucoma diseases in China from its National Medical Products Administration (NMPA).

Due to the rising awareness about eye disorders and the factors mentioned above, the posterior segment eye disorders market is expected to register healthy growth over the forecast period. However, factors such as stringent regulatory policies of different countries and the lack of proper healthcare infrastructure in developing and under-developing countries are likely to restrain this growth.

Posterior Segment Eye Disorders Industry Overview

The market for posterior segment eye disorders is moderately fragmented. Market players are focusing on new product launches, product innovation, regional expansions, and collaborations to increase their market share. The key market players operating in the market include F. Hoffmann-La Roche AG, Regeneron Pharmaceuticals Inc., Rainbow Medical Ltd (Nano Retina), Second Sight Medical, and Merck & Co. Inc.

Posterior Segment Eye Disorders Market Leaders

  1. F. Hoffmann-La Roche AG

  2. Regeneron Pharmaceuticals, Inc.

  3. Rainbow Medical Ltd. (Nano Retina)

  4. Second Sight Medical

  5. Merck & Co., Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Posterior Segment Eye Disorders Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Posterior Segment Eye Disorders Market News

  • In June 2022, Amring Pharmaceuticals Inc. (Amring) received the US FDA approval for generic Timolol Maleate Ophthalmic Solution, USP 0.5%, 60 pack of 0.3mL unit dose vials (AT3 rated generic equivalent of Timoptic in Ocudose).
  • In April 2022, Sandoz launched a generic combination of eyedrop brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%, an AB-rated generic equivalent to AbbVie's COMBIGAN in the United States to lower eye pressure in patients with ocular hypertension (high eye pressure).

Posterior Segment Eye Disorders Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Back of the Eye Disorders
    • 4.2.2 Growing R&D for New Therapies for the Treatment of Posterior Segment Eye Disorders
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Policies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Drugs
    • 5.1.1.1 Small Molecules
    • 5.1.1.2 Biologics
    • 5.1.2 Devices
    • 5.1.2.1 Therapeutic Devices
    • 5.1.2.2 Diagnostic Devices
  • 5.2 By Application
    • 5.2.1 Macular Degeneration
    • 5.2.2 Glaucoma
    • 5.2.3 Diabetic Retinopathy
    • 5.2.4 Other Applications
  • 5.3 By Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Alcon Inc.
    • 6.1.2 Abbvie Inc. (Allergen PLC)
    • 6.1.3 Bausch Health Companies Inc.
    • 6.1.4 F Hoffmann-La Roche
    • 6.1.5 Merck & Co. Inc.
    • 6.1.6 Novartis AG
    • 6.1.7 Santen Pharmaceuticals
    • 6.1.8 Rainbow Medical Ltd (Nano Retina)
    • 6.1.9 Regeneron Pharmaceuticals Inc.
    • 6.1.10 Second Sight Medical Products Inc.
    • 6.1.11 Aerie Pharmaceuticals
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products, Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Posterior Segment Eye Disorders Industry Segmentation

As per the scope of the report, posterior segment eye disorders are also known as the retina, optic nerve, and choroid diseases. The primary disorders include glaucoma, diabetic retinopathy, macular degradation, and others. The report covers the drugs and devices that are used in the diagnosis and treatment of back-eye diseases.

The posterior segment eye disorders market is segmented by product (drugs and devices (therapeutic devices and diagnostic devices), application (macular degeneration, glaucoma, diabetic retinopathy, other applications), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD million) for the above segments.

By Product Drugs Small Molecules
Biologics
Devices Therapeutic Devices
Diagnostic Devices
By Application Macular Degeneration
Glaucoma
Diabetic Retinopathy
Other Applications
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Posterior Segment Eye Disorders Market Research FAQs

How big is the Posterior Segment Eye Disorders Market?

The Posterior Segment Eye Disorders Market size is expected to reach USD 33.86 billion in 2025 and grow at a CAGR of 5.42% to reach USD 44.09 billion by 2030.

What is the current Posterior Segment Eye Disorders Market size?

In 2025, the Posterior Segment Eye Disorders Market size is expected to reach USD 33.86 billion.

Who are the key players in Posterior Segment Eye Disorders Market?

F. Hoffmann-La Roche AG, Regeneron Pharmaceuticals, Inc., Rainbow Medical Ltd. (Nano Retina), Second Sight Medical and Merck & Co., Inc. are the major companies operating in the Posterior Segment Eye Disorders Market.

Which is the fastest growing region in Posterior Segment Eye Disorders Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Posterior Segment Eye Disorders Market?

In 2025, the North America accounts for the largest market share in Posterior Segment Eye Disorders Market.

What years does this Posterior Segment Eye Disorders Market cover, and what was the market size in 2024?

In 2024, the Posterior Segment Eye Disorders Market size was estimated at USD 32.02 billion. The report covers the Posterior Segment Eye Disorders Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Posterior Segment Eye Disorders Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Posterior Segment Eye Disorders Industry Report

Statistics for the 2025 Posterior Segment Eye Disorders market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Posterior Segment Eye Disorders analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Posterior Segment Eye Disorders Market Report Snapshots

Compare market size and growth of Posterior Segment Eye Disorders Market with other markets in Healthcare Industry

Posterior Segment Eye Disorders Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)